Literature DB >> 23881307

VPREB1 deletions occur independent of lambda light chain rearrangement in childhood acute lymphoblastic leukemia.

D S Mangum1, J Downie2, C C Mason2, M S Jahromi3, D Joshi4, V Rodic5, M Müschen6, N Meeker7, N Trede8, J K Frazer9, Y Zhou10, C Cheng10, S Jeha11, C-H Pui11, C L Willman12, R C Harvey12, S P Hunger13, J J Yang14, P Barnette8, C G Mullighan15, R R Miles5, J D Schiffman8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23881307      PMCID： PMC4043450          DOI： 10.1038/leu.2013.223

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  20 in total

Review 1.  Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions.

Authors:  C G Mullighan; J R Downing
Journal:  Leukemia       Date:  2009-02-26       Impact factor: 11.528

Review 2.  Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling.

Authors:  Sebastian Herzog; Michael Reth; Hassan Jumaa
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

3.  Regulation of immunoglobulin light chain gene rearrangements during early B cell development in the human.

Authors:  A Bräuninger; T Goossens; K Rajewsky; R Küppers
Journal:  Eur J Immunol       Date:  2001-12       Impact factor: 5.532

4.  A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study.

Authors:  Monique L Den Boer; Marjon van Slegtenhorst; Renée X De Menezes; Meyling H Cheok; Jessica G C A M Buijs-Gladdines; Susan T C J M Peters; Laura J C M Van Zutven; H Berna Beverloo; Peter J Van der Spek; Gaby Escherich; Martin A Horstmann; Gritta E Janka-Schaub; Willem A Kamps; William E Evans; Rob Pieters
Journal:  Lancet Oncol       Date:  2009-01-08       Impact factor: 41.316

5.  VpreB1/VpreB2/lambda 5 triple-deficient mice show impaired B cell development but functional allelic exclusion of the IgH locus.

Authors:  Takeyuki Shimizu; Cornelia Mundt; Steve Licence; Fritz Melchers; Inga-Lill Mårtensson
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

6.  Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.

Authors:  Charles G Mullighan; Xiaoping Su; Jinghui Zhang; Ina Radtke; Letha A A Phillips; Christopher B Miller; Jing Ma; Wei Liu; Cheng Cheng; Brenda A Schulman; Richard C Harvey; I-Ming Chen; Robert J Clifford; William L Carroll; Gregory Reaman; W Paul Bowman; Meenakshi Devidas; Daniela S Gerhard; Wenjian Yang; Mary V Relling; Sheila A Shurtleff; Dario Campana; Michael J Borowitz; Ching-Hon Pui; Malcolm Smith; Stephen P Hunger; Cheryl L Willman; James R Downing
Journal:  N Engl J Med       Date:  2009-01-07       Impact factor: 91.245

7.  Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia.

Authors:  Charles G Mullighan; Salil Goorha; Ina Radtke; Christopher B Miller; Elaine Coustan-Smith; James D Dalton; Kevin Girtman; Susan Mathew; Jing Ma; Stanley B Pounds; Xiaoping Su; Ching-Hon Pui; Mary V Relling; William E Evans; Sheila A Shurtleff; James R Downing
Journal:  Nature       Date:  2007-04-12       Impact factor: 49.962

8.  Mutations in the human lambda5/14.1 gene result in B cell deficiency and agammaglobulinemia.

Authors:  Y Minegishi; E Coustan-Smith; Y H Wang; M D Cooper; D Campana; M E Conley
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307

9.  Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function.

Authors:  Daniel Trageser; Ilaria Iacobucci; Rahul Nahar; Cihangir Duy; Gregor von Levetzow; Lars Klemm; Eugene Park; Wolfgang Schuh; Tanja Gruber; Sebastian Herzog; Yong-mi Kim; Wolf-Karsten Hofmann; Aihong Li; Clelia Tiziana Storlazzi; Hans-Martin Jäck; John Groffen; Giovanni Martinelli; Nora Heisterkamp; Hassan Jumaa; Markus Müschen
Journal:  J Exp Med       Date:  2009-07-20       Impact factor: 14.307

10.  Normal human B cells display ordered light chain gene rearrangements and deletions.

Authors:  S J Korsmeyer; P A Hieter; S O Sharrow; C K Goldman; P Leder; T A Waldmann
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307
View more
  11 in total

Review 1.  Rationale for targeting the pre-B-cell receptor signaling pathway in acute lymphoblastic leukemia.

Authors:  Markus Müschen
Journal:  Blood       Date:  2015-04-15       Impact factor: 22.113

2.  Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets.

Authors:  Alyssa Bouska; Chengfeng Bi; Waseem Lone; Weiwei Zhang; Ambreen Kedwaii; Tayla Heavican; Cynthia M Lachel; Jiayu Yu; Roberto Ferro; Nanees Eldorghamy; Timothy C Greiner; Julie Vose; Dennis D Weisenburger; Randy D Gascoyne; Andreas Rosenwald; German Ott; Elias Campo; Lisa M Rimsza; Elaine S Jaffe; Rita M Braziel; Reiner Siebert; Rodney R Miles; Sandeep Dave; Anupama Reddy; Jan Delabie; Louis M Staudt; Joo Y Song; Timothy W McKeithan; Kai Fu; Michael Green; Wing C Chan; Javeed Iqbal
Journal:  Blood       Date:  2017-08-11       Impact factor: 22.113

Review 3.  Autoimmunity checkpoints as therapeutic targets in B cell malignancies.

Authors:  Markus Müschen
Journal:  Nat Rev Cancer       Date:  2018-01-05       Impact factor: 60.716

4.  Identification of recurrent noncoding mutations in B-cell lymphoma using capture Hi-C.

Authors:  Alex J Cornish; Phuc H Hoang; Sara E Dobbins; Philip J Law; Daniel Chubb; Giulia Orlando; Richard S Houlston
Journal:  Blood Adv       Date:  2019-01-08

Review 5.  The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemia.

Authors:  J Eswaran; P Sinclair; O Heidenreich; J Irving; L J Russell; A Hall; D P Calado; C J Harrison; J Vormoor
Journal:  Leukemia       Date:  2015-05-06       Impact factor: 11.528

6.  The mutational landscape in pediatric acute lymphoblastic leukemia deciphered by whole genome sequencing.

Authors:  Carl Mårten Lindqvist; Jessica Nordlund; Diana Ekman; Anna Johansson; Behrooz Torabi Moghadam; Amanda Raine; Elin Övernäs; Johan Dahlberg; Per Wahlberg; Niklas Henriksson; Jonas Abrahamsson; Britt-Marie Frost; Dan Grandér; Mats Heyman; Rolf Larsson; Josefine Palle; Stefan Söderhäll; Erik Forestier; Gudmar Lönnerholm; Ann-Christine Syvänen; Eva C Berglund
Journal:  Hum Mutat       Date:  2015-01       Impact factor: 4.878

Review 7.  ZNF423 and ZNF521: EBF1 Antagonists of Potential Relevance in B-Lymphoid Malignancies.

Authors:  Maria Mesuraca; Emanuela Chiarella; Stefania Scicchitano; Bruna Codispoti; Marco Giordano; Giovanna Nappo; Heather M Bond; Giovanni Morrone
Journal:  Biomed Res Int       Date:  2015-12-16       Impact factor: 3.411

8.  An in-depth analysis reveals two new genetic variants on 22q11.2 associated with vitiligo in the Chinese Han population.

Authors:  Xianfa Tang; Hui Cheng; Lu Cheng; Bo Liang; Mengyun Chen; Xiaodong Zheng; Fengli Xiao
Journal:  Mol Biol Rep       Date:  2021-08-04       Impact factor: 2.316

9.  Pax5 loss imposes a reversible differentiation block in B-progenitor acute lymphoblastic leukemia.

Authors:  Grace J Liu; Luisa Cimmino; Julian G Jude; Yifang Hu; Matthew T Witkowski; Mark D McKenzie; Mutlu Kartal-Kaess; Sarah A Best; Laura Tuohey; Yang Liao; Wei Shi; Charles G Mullighan; Michael A Farrar; Stephen L Nutt; Gordon K Smyth; Johannes Zuber; Ross A Dickins
Journal:  Genes Dev       Date:  2014-06-15       Impact factor: 11.361

10.  Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options.

Authors:  Ute Fischer; Michael Forster; Anna Rinaldi; Thomas Risch; Stéphanie Sungalee; Hans-Jörg Warnatz; Beat Bornhauser; Michael Gombert; Christina Kratsch; Adrian M Stütz; Marc Sultan; Joelle Tchinda; Catherine L Worth; Vyacheslav Amstislavskiy; Nandini Badarinarayan; André Baruchel; Thies Bartram; Giuseppe Basso; Cengiz Canpolat; Gunnar Cario; Hélène Cavé; Dardane Dakaj; Mauro Delorenzi; Maria Pamela Dobay; Cornelia Eckert; Eva Ellinghaus; Sabrina Eugster; Viktoras Frismantas; Sebastian Ginzel; Oskar A Haas; Olaf Heidenreich; Georg Hemmrich-Stanisak; Kebria Hezaveh; Jessica I Höll; Sabine Hornhardt; Peter Husemann; Priyadarshini Kachroo; Christian P Kratz; Geertruy Te Kronnie; Blerim Marovca; Felix Niggli; Alice C McHardy; Anthony V Moorman; Renate Panzer-Grümayer; Britt S Petersen; Benjamin Raeder; Meryem Ralser; Philip Rosenstiel; Daniel Schäfer; Martin Schrappe; Stefan Schreiber; Moritz Schütte; Björn Stade; Ralf Thiele; Nicolas von der Weid; Ajay Vora; Marketa Zaliova; Langhui Zhang; Thomas Zichner; Martin Zimmermann; Hans Lehrach; Arndt Borkhardt; Jean-Pierre Bourquin; Andre Franke; Jan O Korbel; Martin Stanulla; Marie-Laure Yaspo
Journal:  Nat Genet       Date:  2015-07-27       Impact factor: 38.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.